Story thread · 2 reports / 2 sources
Impact BioMedical approves 1-for-12.62 reverse stock split
investing.com · 3d
First report: Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley’s Ltd.) — markets.businessinsider.com, 3d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.